Group 2 May 2, 2017 Session V Session V – Empire A: Infectious Disease Evaluators: Louis Portas, Lebanon VAMC; Sharon Blum, Winthrop Univ; Jacqueline Costantino, South County Health 1:20 pm Danan, Eleanor Use and effectiveness of peri-operative cefoxitin or cefotetan versus cefazolin The Johns Hopkins plus metronidazole for prevention of surgical site infection in abdominal surgery patients 1:40 pm Effendi, Muhammad Evaluation of antimicrobial stewardship interventions and acceptance rate in a Yale New Haven Hosp large tertiary academic medical center 2:00 pm Rebrin, Nastja Time Out! Implementation of pharmacist-driven antimicrobial stewardship Baystate Med Center huddles on general medicine floors at an academic medical center 2:20 pm Liu, Erica Optimizing ciprofloxacin use for suspected urinary tract infections: reducing Yale New Haven Hosp inappropriate use and the risk of C. difficile infection 2:40 pm Steiner, Roman Evaluation of initial vancomycin dosing strategy for complicated infections in patients 36 Christiana Care to 50 years of age with normal renal function Session V – Empire B: Infectious Disease Evaluators: Rose O’Flynn, Philadelphia VAMC; Amanda Sowell, The Johns Hopkins Hosp; Joleen Bierlein, Maine Med 1:20 pm Cabanas, Gregory Clinical outcomes with the use of fosfomycin for the treatment of Klebsiella Jersey Shore pneumoniae carbapenemase (KPC) urinary tract infections (UTIs) 1:40 pm Sangiovanni, Ryan Re-treatment with vancomycin (VAN) and subsequent risk of acute kidney injury Albany Stratton VAMC (AKI) among Veterans’ Affairs patients who have previously experienced vancomycin-associated AKI 2:00 pm Meanor, Caitlin Removing Penicillin Allergies: A Pharmacist Assessment and Skin Testing Service Carilion Clinic 2:20 pm Sheridan, Ashley Evaluating the impact of antimicrobial drug shortages on the utilization of Penn Presbyterian alternative agents and patient outcomes at an academic medical center 2:40 pm Nguyen, Nghia Impact of a Beta-Lactam Allergy Label on Initial Therapy Selection in the Johns Hopkins Emergency Department Bayview Session V – Empire C: Quality Assurance Evaluators: Lakshmi Singh, VAMHCS; John Papadopoulos, NYU Langone; Kathleen Belusko, UMass Mem 1:20 pm Lenox, Demi Evaluation of 4-Factor Prothrombin Complex Concentrate Prescribing and Einstein Network Administration Practices 1:40 pm Kibler, Alexandra Safety and efficacy of emergent doses of intravenous levetiracetam in a Penn State Hershey neurological patient population 2:00 pm Vogel, Brittany Influence of a 90 day, $0 mail-order Medicare Part D benefit design on Kaiser Mid-Atlantic medication adherence. 2:20 pm Noss, Kelsey Comparison of prescribing and monitoring habits when ordering two QTc- Einstein Network prolonging agents before and after pharmacist-driven education 2:40 pm Kurian, Jason Evaluation of somatostatin analogs for the prevention of post-operative The Johns Hopkins pancreatic fistula Hosp Group 2 04/21/2017 Session V – Empire D: Quality Assurance Evaluators: Jennifer Kunkel, Hahneman; Amy Nathenson, JH Home Care; Liz O’Gara, Lahey Hosp 1:20 pm Park, Jiyeon Impact of standardized infliximab dose rounding in an outpatient infusion center Englewood 1:40 pm Adedokun, Evaluation of vancomycin dosing and monitoring at an urban, community Adetokunbo hospital in Washington, D.C.: A pre- and post-intervention study Howard Univ Hosp 2:00 pm Bender, Regis Rituximab-induced lung toxicity in patients treated for non-Hodgkin’s lymphoma: Penn State Hershey a retrospective cohort study 2:20 pm Soto-Aviles, Adriana Comparison of day and night shift sedative and analgesic use in a community Suburban Hosp hospital intensive care unit 2:40 pm Pak, Diana Evaluation of acute stroke care management at a community teaching hospital Moses Taylor Session V – Magnolia A: Cardio/Crit Care Evaluators: Jason Mordino, Boston Med Cent; Craig Worby, Dartmouth-Hitchcock; Albert Celidonio, Paoli Hosp PGY2 Evaluator: Regina Yun 1:20 pm Para, Lauren Prescribing patterns of guideline-directed medical therapy following admission Geisinger Med Center for heart failure decompensation 1:40 pm McIntyre, Kelsey Evaluation of the use of platelet function testing in patients receiving P2Y12 Christiana Care inhibitors following percutaneous coronary intervention 2:00 pm Gosek, Katarzyna Evaluating the Impact of Pharmacist-Led Management of Warfarin Therapy Using Penn Presbyterian a Standardized Process While Offering Individualized Assessment of INR Control at an Academic Medical Center: A Pilot Study 2:20 pm Ferenz, Michael Risk factors associated with development of acquired long-QT syndrome and Kennedy Univ Hosp subsequent impact on hospital length of stay and mortality 2:40 pm McMahon, Clare Impact of in-house platelet factor-4 assay on direct thrombin inhibitor use in Carilion Clinic patients with suspected heparin-induced thrombocytopenia Session V – Magnolia B: TOC Evaluators: Nancy Nystrom, Maine Medical; Denise Fu, JH Home Care; Mark Freebery, UMD Eastern Shore 1:20 pm Megano, Danielle Evaluation of the impact of pharmacist-led motivational interviewing on patients Baystate Med Center with chronic obstructive pulmonary disease exacerbations 1:40 pm Bhatt, Krupa Pharmacy initiative to improve outpatient bridging with enoxaparin in patients Tufts with newly-implanted ventricular assist devices 2:00 pm Lee, Yeo Impact of pharmacist interventions at discharge on hospital readmission rates St. Vincent's Med Cent 2:20 pm Chin, Candice Delivery of discharge medications to patients at bedside: evaluation of the Meds- Elliot Health System to-Beds program 2:40 pm Fitzgerald, Daniel The impact of pharmacy services on care transitions to a sub-acute rehabilitation Hunterdon Med Cent facility Group 2 04/21/2017 Session V – Magnolia C: Disease State Mgt Evaluators: Gina Waibel, Reading Hospital; Daryn Norwood, MUMH; AnneMarie Sherwood, Kaiser Mid-Atlantic PGY2 Evaluator: Anita Wong, Maryland VAHCS 1:20 pm McKimmy, Danielle Implementation of health system specialty pharmacy services: a post-transplant Yale New Haven Hosp medication management model 1:40 pm Vysotski, Sora Impact of a clinical pharmacist’s interventions on diabetes control in patients Kingsbrook Jewish with type 2 diabetes mellitus in central Brooklyn 2:00 pm Song, Chelsey Comparison of Bivalirudin and Argatroban Therapy for Patients with The Johns Hopkins Suspected/Confirmed Heparin-Induced Thrombocytopenia Hosp 2:20 pm LeGrand, Meighan Assessing anticoagulation control using time within therapeutic Range (TTR) Howard Univ Hosp 2:40 pm Davidovits, Chava Use of oral antidiabetic medications for inpatient management of type 2 diabetes Kingsbrook Jewish Session V – Magnolia D: Ambulatory Care Evaluators: Sarah Pierce, VAMHCS; Amanda Sturges, Lebanon VAMC; Emily Pherson, The Johns Hopkins Hospital PGY2 Evaluator: Taryn Mondiello, VA Hudson Valley 1:20 pm Saafan, Yasmin Glycemic outcomes after discharge from a pharmacist run Patient Aligned Care JJP VAMC Team (PACT) clinic 1:40 pm Woskov, Joanne- Benefits of a specialty hepatitis c pharmacy within a hospital ambulatory clinic Ritzelle MWHC 2:00 pm Natali, Kayla Evaluation of diabetes-related health outcomes in patients managed by the St. Joseph's Regional ambulatory care pharmacist 2:20 pm Chaudhry, Maheen Adherence rates following implementation of a pharmacist led direct oral Cooley Dickenson anticoagulants clinic 2:40 pm Ebron, Jasmine Evaluating the clinical pharmacists’ impact on medication adherence and clinical Kaiser Mid-Atlantic outcomes in type 2 diabetic patients. Session V – Wildrose A: Ambulatory Care Evaluators: Catherine Sanchez Vega, VAMHCS; Heather Spoonhower, Wilkes-Barre VAMC; Lois Lee, Fredrick Memorial PGY2 Evaluator: Sean Lasota, The Johns Hopkins Hosp 1:20 pm Tolbard, Dallas Evaluation of improving access to naloxone and assessing veterans’ level of Hunter Holmes comfort with naloxone in a Veterans Affair medical center McGuire VAMC 1:40 pm Quinn, Rachel Pharmacist-driven step-down of long term proton pump inhibitor therapy VA Hudson Valley 2:00 pm Mangione, Elise Standardizing the medication procurement process in the ambulatory clinic Yale New Haven Hosp setting 2:20 pm Yu, Victoria Use of a quality assurance tool (International Classification of Diseases, Tenth Hunter Holmes Revision code surveillance) to improve identification and reporting of adverse McGuire VAMC drug events associated with use of anticoagulants at a Veterans’ Affairs Medical Center 2:40 pm Argento, Liliana Evaluation of heart failure clinic at the James J. Peters VA Medical Center JJP VAMC Group 2 04/21/2017 Session V – Wildrose B: Oncology Evaluators: Genevieve Kumapley, St. Peter’s Univ Hosp; Joseph Stuccio, Paoli Hosp; Suzanne Nesbit, The Johns Hopkins Hosp 1:20 pm Robusto, Lindsay Incidence of intractable nausea and vomiting in non-small-cell lung cancer Johns Hopkins (NSCLC) patients receiving moderate-emetogenic chemotherapy regimens Bayview 1:40 pm Goscicki, Breana Time to first antibiotic administration in adult oncology patients that present to Lehigh Valley the emergency department and infusion centers 2:00 pm Dunn, Danielle Evaluating the impact of granulocyte colony-stimulating factor on bleomycin- Maine General induced pulmonary toxicity 2:20 pm Kaitharath, Megha Evaluation of efficacy and toxicity profiles of two liposomal doxorubicin Montefiore Med Cent formulations - Doxil™ and Lipodox™ - a retrospective analysis 2:40 pm Attilio, Mark Assessment of Immunosuppression in Allogeneic Stem Cell Transplantation and Penn State Hershey Risk for Graft